Contract with Customer, Liability, Current of BIOMARIN PHARMACEUTICAL INC from 31 Dec 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
BIOMARIN PHARMACEUTICAL INC quarterly Contract with Customer, Liability, Current in USD history and change rate from 31 Dec 2018 to 31 Dec 2024.
  • BIOMARIN PHARMACEUTICAL INC Contract with Customer, Liability, Current for the quarter ending 31 Dec 2024 was $1,369,000, a 70% decline year-over-year.
Source SEC data
View on sec.gov
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)

BIOMARIN PHARMACEUTICAL INC Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $1,369,000 -$3,251,000 -70% 31 Dec 2024 10-K 24 Feb 2025 2024 FY
Q3 2024 $2,346,000 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $1,912,000 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 $5,151,000 31 Mar 2024 10-Q 26 Apr 2024 2024 Q1
Q4 2023 $4,620,000 +$3,909,000 +550% 31 Dec 2023 10-K 24 Feb 2025 2024 FY
Q4 2022 $711,000 -$6,245,000 -90% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $415,000 -$9,244,000 -96% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $305,000 -$10,719,000 -97% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $306,000 -$10,921,000 -97% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $6,956,000 +$6,804,000 +4476% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 $9,659,000 -$1,271,000 -12% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $11,024,000 +$5,674,000 +106% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $11,227,000 +$3,338,000 +42% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $152,000 -$12,885,000 -99% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $10,930,000 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $5,350,000 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $7,889,000 31 Mar 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 $13,037,000 +$11,570,000 +789% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q4 2018 $1,467,000 31 Dec 2018 10-K 27 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.